Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community: 3-year follow-up study

International Journal of Geriatric Psychiatry

Volumn 27, Issue 3, 2012, Pages 321-326

  Watanabe, Itaru ^a   Li, Guang Ying ^b   Imamura, Yoshiomi ^a   Nabeta, Hiromi ^a   Kunitake, Yutaka ^a   Ishii, Hironobu ^a   Haraguchi, Masanori ^a   Kojima, Naoki ^c   Yamada, Shigeto ^a  

^a SAGA UNIVERSITY   (Japan)

^b CHANGCHUN UNIVERSITY   (China)

^c Kojima Hospital   (Japan)

Author keywords

BDI; depressive state; MHPG; saliva

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE DEFECT; COMMUNITY ASSESSMENT; DEPRESSION; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FAMILY; FEMALE; FOLLOW UP; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; RURAL POPULATION; SOCIAL STATUS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; PSYCHIATRIC STATUS RATING SCALES; RURAL POPULATION; SALIVA; SEX FACTORS;

EID: 84856334862     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2729     Document Type: Article

References (22)

1. Asberg M, Bertilsson L, Mårtensson B, et al,. 1984. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 69: 201-219. (Pubitemid 14155019)
2. Azorin JM, Raucoules D, Valli M, et al,. 1990. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls. Neuropsychobiology 23: 18-24. (Pubitemid 20366587)
3. Barrett-Connor E, Palinkas LA,. 1994. Low blood pressure and depression in older men: a population based study. BMJ 308: 446-449. (Pubitemid 24084185)
4. Del Rio G, Velardo A, Zizzo G, et al,. 1994. Effect of estradiol on the sympathoadrenal response to mental stress in normal men. J Clin Endocrinol Metab 79: 836-840. (Pubitemid 24286412)
5. Ehnvall A, Sjögren M, Zachrisson CG, Ågren H,. 2003. Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness. J Affect Dis 74: 185-189. (Pubitemid 36428700)
6. Eisenhofer G, Kopin I, Goldstein D,. 2004. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56: 331-349. (Pubitemid 39096594)
7. Garvey MJ, Tuason VB,. 1996. Urinary levels of 3-methoxy-4- hydroxyphenylglycol predict symptom severity in selected patients with unipolar depression. Psychiatry Res 62: 171-177. (Pubitemid 26174858)
8. Geracioti TD, Jr, Loosen PT, Ekhator NN, et al,. 1997. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depress Anxiety 6: 89-94. (Pubitemid 28079895)
9. Goldberg J, Breckenridge J, Sheik JI,. 2003. Age differences in symptoms of depression and anxiety: examining behavioral medicine outpatients. J Behav Med 26: 119-132. (Pubitemid 36528186)
10. Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A,. 2007. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 74: 20-25.
11. Heinz A, Weingartner H, George D, et al,. 1999. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89: 97-106.
12. Koslow SH, Maas JW, Bowden CL, et al,. 1983. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry 40: 999-1010. (Pubitemid 13049076)
13. Li GY, Ueki H, Yamamoto Y, Yamada S,. 2006. Association between the scores on the general health questionnaire-28 and the saliva levels of 3-methoxy-4-hydroxyphenylglycol in normal volunteers. Biol Psychol 73: 209-211. (Pubitemid 44062095)
14. Li GY, Watanabe I, Kunitake Y, et al,. 2008. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population. Psychiatr Clin Neurosci 62: 562-567.
15. Meyers BS,. 1998. Depression and dementia: comorbidities, identification, and treatment. J Geriatr Psychiatry Neurol 11: 201-205. (Pubitemid 29178747)
16. Okuno K, Yoshimura R, Ueda N, et al,. 2011. Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan. Psychiatry Res 186: 326-332.
17. Reuster T, Rilke O, Oehler J,. 2002. High correlation between salivary MHPG and CSF MHPG. Psychopharmacol Berl 162: 415-418. (Pubitemid 35001904)
18. Ross AE, Flaa A, Høieggen A, et al,. 2001. Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects. Scand Cardiovasc J 35: 307-312. (Pubitemid 34100810)
19. Samson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ,. 1992. Learned helplessness and urinary MHPG levels in unipolar depression. Am J Psychiatry 149: 806-809.
20. Vestergaard P, Sørensen T, Hoppe E, et al,. 1978. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58: 88-96. (Pubitemid 8397271)
21. Yamada S, Yamauchi K, Yajima J, et al,. 2000. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders. Psychiatry Res 93: 217-223. (Pubitemid 30175952)
22. Yang RK, Yehuda R, Holland DD, Knott PJ,. 1997. Relationship between 3-methoxy- 4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Biol Psychiatry 42: 821-826. (Pubitemid 27468210)